A study to compare bioavailability of AZD5055 film-coated tablet with AZD5055 oral suspension and to assess the effect of food and an acid reducing agent on pharmacokinetics (PK) of AZD5055 in healthy subjects.

Trial Identifier: D8960C00002
Sponsor: AstraZeneca
Collaborator:
Parexel
NCTID:: NCT05630677
Start Date: November 2022
Primary Completion Date: February 2023
Study Completion Date: February 2023
Condition: Healthy Volunteers

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version

Trial Locations

Country Location
US, MD Brooklyn, MD, US, 21225